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Left ventricular hypertrophy due to aortic stenosis, hy-
pertension and other forms of heart disease is associated 
with abnormalities of diastolic function. It is uncertain 
whether these changes are an inherent consequence of 
the hypertrophic process or represent additional patho-
logic factors. To investigate this issue, echocardiographic 
indexes of left ventricular early diastolic function in highly 
trained athletes were compared with those in age-matched 
normal control subjects. Athletes were equally classified 
into two groups: II swimmers who had a pattern of 
myocardial hypertrophy with normal wall thickness to 
dimension ratio and 11 power lifters whose wall thick-
ness to dimension ratio was increased. 
The peak rates of left ventricular dimension increase 
and wall thinning in swimmers and power lifters were 
greater than in control subjects despite significantly higher 
left ventricular wall thickness and left ventricular mass 
Left ventricular hypertrophy due to primary myocardial dis-
ease, valvular aortic stenosis or hypertension has been as-
sociated with abnormal diastolic function (1-4). The factors 
that have been suggested (5.6) as being responsible include 
increased wall thickness, altered geometry, regional vari-
ation in wall thickness, interstitial fibrosis, loss of contractile 
elements, delayed intraventricular conduction and altera-
tions in the reuptake of the myoplasmic activating calcium. 
It is uncertain whether the described abnormalities are a 
necessary consequence of the hypertrophic process or relate 
to the nature of the primary hypertrophic stimulus. One 
approach to this issue is to examine diastolic performance 
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index in the athletes. This increase in diastolic function 
indexes was associated with greater ventricular size and 
systolic performance. Normalization of the peak rate of 
dimension increase for end-diastolic dimension and ad-
justment of the peak rate of wall thinning for the frac-
tional systolic thickening resolved any differences be-
tween groups. Thus, after the effects of ventricular size 
and systolic function were taken into consideration, di-
astolic function was normal in these subjects with con-
siderable physiologic hypertrophy. This is in contrast to 
the findings in patients with hypertrophy associated with 
left ventricular pressure or volume overload, and sug-
gests that abnormalities of diastolic function seen in 
pathologic hypertrophy are due to factors other than 
cardiac hypertrophy itself. 
(J Am Coll Cardiol 1985;6:545-9) 
in subjects with hypertrophy not associated with disease. 
However, few studies (7,8) have addressed the effect of 
physiologic hypertrophy on diastolic function. This study 
examines noninvasive indexes of early diastolic function in 
two groups of elite athletes with substantial degrees of ec-
centric or concentric left ventricular hypertrophy. 
Methods 
Study group. The study group consisted of 22 athletes 
(II swimmers and II power lifters, aged 17 to 30 years, 
mean 22) and 22 age-matched healthy control subjects. 
Swimmers were recruited from a swim team with a training 
program of 25 to 30 hlweek; all had more than 5 years of 
competitive participation. Power lifters were all participants 
in national level competition within the prior 6 months and 
had more than 4 years of serious lifting experience. Control 
subjects were healthy, non sedentary individuals who par-
ticipated in athletic endeavors on a strictly amateur level 
and were not engaged in any routine training program. All 
were free of known cardiovascular disease, were taking no 
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cardioactive medications and had normal physical exami-
nation, electrocardiogram and intracardiac anatomy by two-
dimensional echocardiqgraphy. 
Echocardiography. High speed (l00 mm/s) M-mode 
echocardiographic recordings of the left ventricular minor 
axis and simultaneous phonocardiogram were obtained us-
ing either an Advanced Technology Laboratories (ATL) 
real-time digital scanner or an Irex system II ultrasound 
module. High quality tracings were selected for computer 
analysis on a Franklin Quantic 1200 (Bruce Franklin, Inc.) 
echocardiographic review station. This device is equipped 
with a digitizing pad with a sampling rate of 80 points/cm, 
yielding a net digitizing rate of 800 points/so Three to five 
beats were digitized for each subject, including the left 
ventricular septal endocardium and the free wall endocar-
dium and epicardium. 
Measurements. From the digitized data, the following 
instantaneous measurements are derived: I) the left ven-
tricular internal dimension throughout the cardiac cycle, 
including end-diastole taken at the Q wave on the electro-
cardiogram and end-systole taken at the time of aortic valve 
closure (that is, the first high frequency component of aortic 
second heart sound); 2) the first derivative of left ventricular 
dimension including the magnitude and timing of the peak 
rate of dimension change; 3) the left ventricular posterior 
wall thickness throughout the cardiac cycle with end-dias-
tole and end-systole as defined previously; and 4) the first 
derivative of left ventricular wall thickness, including the 
magnitude and timing of the peak rate of wall thinning. 
Fractional shortening was calculated as the difference 
between end-diastolic and end-systolic dimension divided 
by end-diastolic dimension. Fractional wall thickening was 
calculated as the end-diastolic to end-systolic wall thickness 
change divided by end-diastolic wall thickness. Left ven-
tricular mass was calculated by modification of the formula 
of Devereux and Reichek (9): 
Mass = 1.04 [(D + 2h)3 - D3] - 14 g, 
where D and h represent end-diastolic dimension and wall 
thickness, respectively. Left ventriqIlar mass index was 
calculated by dividing mass by body surface area. 
Normalized peak rate of dimension change was calcu-
lated as (dD/dt)maxiEDD, where (dDIDt)max = peak rate of 
dimension increase and EDD = end-diastolic dimension. 
Normalized peak rate of wall thinning was calculated as 
(-dh/dt)max/FWT, where (-dh/dt)max = peak rate of wall 
thinning and FWT = fractional wall thinning. The best 
method for adjusting these indexes for ventricular size and 
systolic function is controversial (l, 10-12). In a previous 
study (13) in normal subjects we found the peak rate of 
chamber enlargement to be dependent on a variety of in-
teracting factors including end-diastolic dimension. Peak 
rate of wall thinning was found to correlate most closely 
with fractional wall thickening (13). Large differences in 
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end-diastolic dimensions and fractional wall thickening were 
found between the athletes and control subjects in our study. 
The extent to which these differences may contribute to any 
observed variation in diastolic function was therefore ex-
amined by directly adjusting peak filling rate for end-
diastolic dimension and peak thinning rate for fractional wall 
thickening. 
Statistics. Data are expressed as mean ± I SD unless 
otherwise noted. Comparisons among the three groups were 
made by one-way analysis of variance; overall differences 
were considered significant for p less than 0.05. Compar-
isons between individual groups were then performed using 
Bonferroni's method for multiple simultaneous comparisons. 
Results 
Comparative data for control subjects, swimmers and 
power lifters are given in Tarle I. As expected, body surface 
area was significantly greater in the power lifters. Both 
groups of athletes when compared with control subjects had 
significantly larger end-diastolic dimension with no differ-
ence in end-systolic dimension. Wall thickness was in-
creased in power lifters at both end-diastole and end-
systole. Swimmers had significantly increased wall thick-
ness at end-systole only. Both fractional shortening and 
fractional wall thickening were increased in swimmers. Power 
lifters had increased fractional shortening with normal wall 
Table 1. Echocardiographic Measurements 
Control Power 
Subjects Swimmers Lifters 
(n = 22) (n = I\) (n = II) 
Age (yr) 22 ± 6 21 ± 4 24 ± 3 
BSA (m2) J.7 ± 0.2 I.8 ± 0.2 2.3 ± 0.2* 
EDD (cm) 4.8 ± 0.4 5.4 ± 0.5* 5.4 ± 0.7* 
ESD (cm) 3.2 ± 0.4 3.6 ± 0.4 3.4 ± 0.4 
EDh (cm) 0.9 ± 0.1 1.0 ± 0.1 1.3 ± 0.2*t 
ESh (cm) 1.5 ± 0.2 1.8 ± 0.1* 2.2 ± 0.3*t 
FS (%) 32.3 ± 3.8 34.3 ± 2.6* 37.4 ± 3.3*t 
FWT (%) 39.6 ± 6.8 43.3 ± 4.4* 39.4 ± 5.6 
LVMI (g/m2) 98 ± 26 136 ± 35* 165 ± 57*t 
HR (beals/min) 72 ± 16 65 ± 13 74 ± 14 
(dp/dT)max (cmls) 13.6 ± 3.2 18.7 ± 2.0* 16.5 ± 4.2*t 
Az-(dDldT)max (s) 0.48 ± 0.05 0.46 ± 0.05 0.46 ± 0.07 
(-dh/dt)max (cmls) 8.4 ± J.5 I J.7 ± 1.5* 10.6 ± 2.0*t 
Ar( -dh/dt)max (s) 0.48 ± 0.04 0.46 ± 0.06 0.45 ± 0.06 
*p < 0.05 compared with control subjects; tp < 0.05 compared with 
swimmers. A2-(dD/dt)max = time interval from aortic valve closure to peak 
rate of chamber enlargement; A2-(-dhldt)max = time interval from aortic 
valve closure to peak rate of wall thinning; BSA = body surface area; 
(dD/dt)n,.x = peak rate of chamber enlargement; (-dh/dt)max = peak rate 
of wall thinning; EDD = end-diastolic dimension; EDh = end~diastolic 
wall thickness; ESD = end-systolic dimension; f:Sh = end-systolic wall 
thickness; FS = fractional shortening; FWT = fractional wall thickening; 
HR = heart rate; LVMI = left ventricular mass index. 
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thickening. Left ventricular mass index was significantly 
increased in both groups of athletes compared with that in 
control subjects, being significantly greater in power lifters 
than in swimmers. There was a trend toward slower heart 
rates in swimmers but the difference did not attain statistical 
significance. 
The peak rate of dimension increase was significantly 
higher for both sets of athletes than for control subjects, 
with significantly higher values for swimmers than for power 
lifters. The peak rate of wall thinning was greater in swim-
mers than in control subjects or power lifters. and power 
lifters had a significantly higher peak rate of wall thinning 
than did control subjects. The timing of the peak rates of 
dimension increase and wall thinning was not significantly 
different for either group. 
The significant differences in peak chamber enlargement 
rate between groups appeared to be due partly to differences 
in ventricular size. Thus, when adjusted for end-diastolic 
dimension (Fig. 1), normalized peak chamber enlargement 
rate was not different for the three groups. The variation in 
peak wall thinning rate between groups was associated with 
concomitant variations in fractional wall thickening. When 
adjusted for systolic performance, the normalized peak rate 
of wall thinning was not different for the three groups 
(Fig. 2). 
Figure 1. Relative peak. rate of dimension change (above) and 
normalized peak. rate of dimension change (below) in 11 swimmers 
(S), 11 power lifters (L) and 22 control subjects (C). After nor-
malization for end-diastolic dimension there were no differences 
among groups. 
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Figure 2. Relative peak rate of wall thinning (above) and nor-
malized peak rate of wall thinning (below) in 11 swimmers (S), 
11 power lifters (L) and 22 control subjects (C). Variation among 
groups could be explained by differences in systolic fractional wall 
thickening as no difference remained after normalization. 
Normal diastolic function. Diastole can be divided into 
an early period of active, energy-consuming relaxation fol-
lowed by a passive filling phase (14). The overlap that 
occurs between these two periods depends on the uniformity 
and completeness of the relaxation process (15). Relaxation 
appears to be dependent on the rate of myofibril inactivation 
and the loading conditions (16), whereas the passive filling 
phase is dependent on intrinsic elastic, viscous and inertial 
properties of the myocardium as well as certain external 
factors, predominant among which are the right ventricle 
and pericardium (17). Hypertrophy due to hypertension and 
valvular disease has been associated with abnormalities of 
both phases of diastole (3-5,14). The period of early dia-
stolic rapid filling and wall thinning coincides with the tran-
sition between the active and passive phases of diastole and 
appears to be dependent on the combined effects of intrinsic 
myocardial properties, inactivation and loading conditions 
(1,2,12,13,18). Abnormalities of this period of diastole have 
been similarly noted (1,2,4,12,19-22) in various pathologic 
conditions associated with myocardial hypertrophy. 
Diastolic function in physiologic hypertrophy. 
Hypertrophy that occurs in response to the stimulus of 
chronic exercise (that is, physiologic hypertrophy) does not 
appear to result in similar abnormalities in early diastolic 
function. The athletes in our study had a significant increase 
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in left ventricular mass, even when this value was normal-
ized for body surface area. Despite this absolute and relative 
increase in left venticular mass, the peak rates of dimension 
increase and wall thinning were significantly increased. We 
(12) and others (21) have previously noted a direct relation 
between the degree of left ventricular hypertrophy and im-
paired filling in patients with pathologic hypertrophy. In 
athletes with either concentric (increased wall thickness to 
dimension ratio) or eccentric (normal wall thickness to di-
mension ratio) hypertrophy, the opposite trend was observed. 
Few previous studies (7,8,23) of diastolic function in 
physiologic hypertrophy have been performed. The diastolic 
properties of the left ventricle evaluated by the diastolic 
pressure-length relation (8,23), peak negative rate of rise 
of pressure (dP/dt) (23,24) and peak rate of chamber en-
largement (23) have been found to be normal or increased 
in conditioned animals. Long-distance runners were found 
(7) to have greater peak rates of dimension increase com-
pared with those of age-matched normal subjects, with even 
greater differences seen during exercise. Similar increases 
of the peak rates of chamber enlargement and wall thinning 
were found in our study for swimmers, who also displayed 
an eccentric pattern of hypertrophy, and for power lifters, 
whose pattern of hypertrophy more closely resembles that 
seen in aortic stenosis or hypertension. 
Determinants of abnormal diastolic function. There 
are a number of interacting factors that may account for 
these findings and for the differences between pathologic 
and physiologic hypertrophy. Left ventricular filling and 
wall thinning depend in a complex fashion on ventricular 
size, function, contractile state and loading conditions 
(11,13,16). In addition to increased indexes of early dia-
stolic function, the athletes in this study had increased ven-
tricular size and systolic function. The augmentation of di-
astolic function in these subjects appears to be secondary 
to these factors since no differences were found after nor-
malization. In contrast, subjects with aortic stenosis have 
reduced filling and wall thinning rates, even after adjustment 
for ventricular size and systolic function (12). Another po-
tential source of variation relates to the fact that the athletes 
were assessed in the "unloaded" state (that is, the hemo-
dynamic stress that leads to hypertrophy was not active at 
the time of evaluation), whereas, in general, subjects with 
aortic stenosis or hypertension are assessed with the hemo-
dynamic load present. However, in the well compensated 
patient with aortic stenosis, peak wall stress is normal or 
low (25,26). Thus, early diastolic function would be either 
unaltered or increased in response to this influence (13,16). 
Differences in contractile state could contribute to the dif-
ferences in diastolic function. This appears unlikely, how-
ever, because abnormal relaxation has been observed in 
patients with aortic stenosis who have a normal contractile 
state (27). Additionally, we (28) and others (7) found normal 
contractile function in highly trained subjects. Finally, train-
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ing could have primary effects on the activator calcium 
reuptake process. At present, there is no data to address the 
latter hypothesis. 
Conclusions. Athletes with significant physiologic hy-
pertrophy display augmented early diastolic function that 
appears to be secondary to increased systolic function and 
cardiac size. Diastolic abnormalities in subjects with patho-
logic hypertrophy are unlikely to be related to increased 
wall thickness alone, but must reflect intrinsic myocardial 
abnormalities, altered systolic function, or both. 
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